Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Moodys
Cantor Fitzgerald
Deloitte
Novartis
Mallinckrodt
Chinese Patent Office
Citi
Federal Trade Commission

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,182,763

« Back to Dashboard

Summary for Patent: 4,182,763

Title: Buspirone anti-anxiety method
Abstract:Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.
Inventor(s): Casten; George P. (Evansville, IN), McKinney; Gordon R. (Evansville, IN), Newton; Roger E. (Evansville, IN), Tompkins; E. Crosby (Evansville, IN), Weikel, Jr.; John H. (Mt. Vernon, IN)
Assignee: Mead Johnson & Company (Evansville, IN)
Application Number:05/908,597
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 4,182,763

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia526202► Subscribe
Australia4729579► Subscribe
Belgium876455► Subscribe
Germany2920739► Subscribe
JapanS54163587► Subscribe
JapanS611008► Subscribe
Philippines14486► Subscribe
South Africa7902456► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Chubb
Mallinckrodt
Healthtrust
Cipla
Accenture
Colorcon
McKinsey
Covington
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot